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Background:p97 cooperateswith cofactors to control various aspects of cellular homeostasis.Mutations at the interdomain
interface cause a multisystem degenerative disorder.
Results: We identified three binding epitopes on p97 for the N-terminal domain of cofactor UBXD1 (UBXD1-N), including
disease-associated residues. Binding reduced p97 ATPase activity.
Conclusion: UBXD1-N modulates interdomain communication and activity of p97.
Significance: The polyvalent binding mode defines a new subset of p97 cofactors.
Valosin-containing protein/p97 is an ATP-driven protein
segregase that cooperates with distinct protein cofactors to con-
trol various aspects of cellular homeostasis. Mutations at the
interface between the regulatory N-domain and the first of two
ATPase domains (D1 and D2) deregulate the ATPase activity
and cause a multisystem degenerative disorder, inclusion body
myopathy associated with Paget disease of bone and frontotem-
poral dementia/amyotrophic lateral sclerosis. Intriguingly, the
mutations affect only a subset of p97-mediated pathways corre-
lating with unbalanced cofactor interactions and most promi-
nently compromised binding of the ubiquitin regulatory X
domain-containing protein 1 (UBXD1) cofactor during endoly-
sosomal sorting of caveolin-1. However, how the mutations
impinge on the p97-cofactor interplay is unclear so far. In cell-
based endosomal localization studies, we identified a critical
role of the N-terminal region of UBXD1 (UBXD1-N). Biophysi-
cal studies using NMR and CD spectroscopy revealed that
UBXD1-N can be classified as intrinsically disordered. NMR
titration experiments confirmed a valosin-containing protein/
p97 interaction motif and identified a second binding site at
helices 1 and 2 of UBXD1-N as binding interfaces for p97. In
reverse titration experiments, we identified twodistant epitopes
on the p97 N-domain that include disease-associated residues
and an additional interaction between UBXD1-N and the D1D2
barrel of p97 that was confirmed by fluorescence anisotropy.
Functionally, binding of UBXD1-N to p97 led to a reduction of
ATPase activity and partial protection from proteolysis. These
findings indicate that UBXD1-N intercalates into the p97-ND1
interface, thereby modulating interdomain communication of
p97 domains and its activity with relevance for disease patho-
genesis. We propose that the polyvalent binding mode charac-
terized for UBXD1-N is a more general principle that defines a
subset of p97 cofactors.
Valosin-containing protein (VCP)3/p97 (also called Cdc48)
is an abundant “ATPases associated with diverse cellular activ-
ities” (AAA)-type ATPase, which is involved in many pathways
that ensure cellular homeostasis (1, 2). These functions include
proteasome-mediated degradation of misfolded or damaged
proteins, key signaling pathways, and endolysosomal sorting
and autophagy (3–5). To mediate the diverse functions, p97
cooperateswith distinct cofactor proteins in different processes
(1, 6, 7). Around 30 cofactors have been identified that bind p97
via specific interaction domains (UBX, UBX-like, PUB, and
PUL) or linear motifs (VIM, SHP box, and VCP-binding motif)
and serve as substrate adapters, targeting factors, ormodulators
of p97 activity (4, 6, 7).
p97 is considered a “protein segregase” that structurally reor-
ganizes proteins and separates them from binding partners or
cellular structures (3, 8). It acts as a macromolecular complex
with its protomers building up a hexameric barrel structure.
The two ATPase domains (D1 and D2) form two concentric
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rings, and the peripheral N-domain is coplanar with or slightly
above the D1 domain, depending on the nucleotide state of the
ATPase domains (9, 10). Substrate adapters and other cofactors
bind either to the N-domain or the C-terminal tail of p97,
depending on their binding domains (7). How force is transmit-
ted onto substrate proteins is unclear so far, but it involves
movements of theN-domains relative to theD1 ring.N-domain
motions are coupled toATPhydrolysis inD2 through a chain of
conformational changes that are transmitted along the D1D2
linker, the D1 domain, and the ND1 linker (9, 11).
Whereas VCP/p97 knock-out is embryonic lethal, missense
mutations in the ND1 interface cause systemic late onset
degenerative disorders in humans called inclusion body myop-
athy associated with Paget disease of bone and frontotemporal
dementia/amyotrophic lateral sclerosis that affect muscle,
bone, and cortical andmotor neurons (12, 13). The exact patho-
genesis is unclear so far, but the prominent feature of affected
tissues and tissue culture cell models includes defects in the
endolysosomal system with impaired endosomal trafficking of
caveolin-1 (CAV1) and autophagosome maturation (4, 5, 14,
15). Intriguingly, disease-associated mutations all cluster at the
ND1 interface, consistentwith deregulatedATPase activity (11,
16–18). Moreover, the mutations cause unbalanced cofactor
interaction including the loss of UBXD1 binding (14, 19). As
UBXD1 is involved in p97-mediated endosomal sorting of
CAV1 and affected by p97 mutations (14), UBXD1 is likely
directly connected to the pathogenesis. Additionally, UBXD1 is
unusual among the p97 cofactors as it binds p97 in two regions,
at the p97 C terminus via a PUB domain and at the p97 N-do-
mainwith a short linear interactionmotif termedVIM; an addi-
tional UBX domain, which usually binds the N-domain of p97,
is not functional (20).
During our cell biological studies of respective binding
domains, we noticed that additional moieties in the N-terminal
region ofUBXD1 (UBXD1-N) are involved in targetingUBXD1
to p97 onCAV1-containing endosomes.We therefore analyzed
the solution structure of UBXD1-N and its interaction with
p97.We discovered a yet unappreciated second binding site for
UBXD1-N on the p97 N-domain including the ND1 linker.
Moreover,we found thatUBXD1-Nalso binds theD1D2barrel.
Interestingly, we observed a modulation of the p97 ATPase
activity by UBXD1-N, indicating that UBXD1-N fixes the
N-domain of p97 (p97-N) in a “down” position and concomi-
tantly favors amore compact conformation for p97. Among the
residues in the N-domain of p97 targeted by UBXD1-N are
critical amino acids frequently affected by disease-associated
mutations, suggesting that the specific binding mode of the
UBXD1 cofactor to p97may explain the compromised function
of the p97UBXD1 complex in the context of the disease.
Experimental Procedures
Cell-based Experiments—The human CAV1-HA and
UBXD1-GFP constructs were described elsewhere (14, 21, 22).
pEGFP-UBXD1–5xPUB-GFP was generated by QuikChange
mutagenesis, resulting in the following codon changes: N184A,
K193A, Y194A, K198A, and N201A in the PUB domain
as described elsewhere (20). pEGFP-UBXD1-RL-GFP was
mutated to code for changes R62A/L63A in the VIM as defined
by Stapf et al. (23). The constructs coding for the different vari-
ants of UBXD1-GFP were cotransfected with the CAV1-HA
construct in U2OS parental cells using the JetPrime reagent
(Polyplus, Illkirch, France) according to the manufacturer’s
protocol. After 24 h of co-expression, cells were analyzed by
immunofluorescence staining or Western blotting. Cells were
lysed for analysis in Western blotting as described elsewhere
(14). Antibodies used were anti-HA (Sigma), anti-GFP (Roche
Applied Science), and anti--tubulin (Sigma). For immunoflu-
orescence staining, cells were fixed in 4% paraformaldehyde for
20 min, immunostained with an anti-HA antibody (Covance,
Munster, Germany) to detect CAV1-HA, and visualized by
epifluorescence microscopy. Images were taken on a Nikon
Eclipse Ti microscope with the Andor DR-328G-C01-SIL cam-
era. Image acquisition was driven by Andor IQ software (scale
bar, 10 m).
Plasmid Constructs for Recombinant Protein Expression—
Different UBXD1 constructs (amino acids 1–133, 32–133, and
1–80) and the D1D2 domain of p97 (amino acids 200–806)
were cloned into a modified pET41 vector (Invitrogen) as
described elsewhere (24) with an N-terminal GST tag and
a PreScission protease cleavage site. Primers used were as
follows: UBXD1-N(1–80): fw, 5-CACACAGGGCCCATGA-
AAAAATTCTTCCAG; rv, 5-GGTTGGCTCGAGCTTAAC-
GGATGGTATCCTGAGATGTTG; UBXD1-N(32–133): fw,
5-CACACAGGGCCCCACAAAGAGAAGCCGAACCAG;
rv, 5-GGTTGGCTCGAGCTTACCTCAG GGTGGCAC-
CAG; p97-D1D2: fw, 5-CACACAGGGCCCGAAGTAGGG-
TATGATGACATTGG; rv, 5-GGTTGGCTCGAGCTTAGC-
CATACAGGTCATCATC. DreamTaq DNA polymerase was
purchased from Thermo Scientific (Schwerte, Germany), and
restrictions enzymes ApaI and XhoI (Fast Digest) and T4 ligase
were from Fermentas (Schwerte, Germany). All constructs
were verified by Sanger sequencing (GATC GmbH, Cologne,
Germany). From previous pulldown experiments (data not
shown), the construct UBXD1-N(1–133) was proven to be
sufficient for p97-N binding. After nuclear magnetic resonance
(NMR) titration experiments of 15N-labeled UBXD1-N with
p97-N, it became clear that for this interaction only residues in
the first part up to Arg80 are needed. As high molecular weight
and the resulting high rotational correlation times hamper
NMR analysis, the smaller but sufficient fragment 1–80 of UB-
XD1-N was used for NMR studies of UBXD1-Np97-N
complex formation. The construct p97-N(1–213) was provided
in a pProEx vector (Invitrogen) with an N-terminal His6 tag.
UBXD1mutants (D11A/I12A and R62A/L63A) were produced
with theQ5 site-directedmutagenesis kit (NewEnglandBiolabs,
Frankfurt am Main, Germany) according to the user’s manual.
Primers used were as follows: UBXD1-ND11A/I12A: fw, 5-CAGG-
AGTTCAAAGCGGCCGCGAAGTTCAAGAGCGCC; rv, 5-
GGCGCTCTTGAACTTCGCGGCCGCTTTGAACTCCTG;
UBXD1-NR62A/L63A: fw, 5-ACGCTCTGGCAGCGGCGGAGC-
AGAAACAGTC; rv, 5-GACTGTTTCTGCTCCGCCGCTG-
CCAGAGCGT.
Expression of Recombinant Proteins and Cell Lysis—Exp-
ression constructs were transformed into Escherichia coli
BL21(DE3)T1r (Sigma-Aldrich). 100 ml of overnight cultures
of transformed bacteria were resuspended in 4 liters of LB
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medium and grown to an A600 of 0.8. For isotope labeling (15N
and/or 13C) studies, 1 liter of LB medium was inoculated with
the overnight culture and grown to anA600 of 0.8. Subsequently,
cells were pelleted by centrifugation (3,000  g, 15 min, room
temperature), resuspended in 4 liters of M9 medium supple-
mentedwith 1 g/liter [15N]ammonium chloride and/or 4 g/liter
[13C]glucose, and again grown to anA600 of 0.8. After induction
of protein expression with 250 M isopropyl -D-1-thiogalac-
topyranoside, cells were shaken further for 6 h at 30 °C for
UBXD1 constructs and overnight at 30 °C for p97 constructs.
For cell lysis, cells were centrifuged (5,500  g, 20 min, 4 °C),
resuspended in low salt buffer (20mMTris-HCl, 50mMNaCl, 1
mMPMSF, pH 7.4), and frozen. After a freezing cycle, cells were
incubated with 300 mg of lysozyme for 1 h at 4 °C followed by
sonication. The cell lysate was ultracentrifuged (90,000 g, 70
min, 4 °C), and the filtrated supernatant was used for
purification.
Purification of Recombinant UBXD1 and p97 Constructs—
Theproteinmixture containingGST-taggedUBXD1-Nor p97-
D1D2 protein was applied to a glutathione column (Macherey
and Nagel, Dueren, Germany) in buffer 1 (20 mM Tris, 150 mM
NaCl, pH 7.4) and eluted with buffer 1 additionally containing
20 mM glutathione. The GST tag was removed by PreScission
protease. The UBXD1 constructs were separated from the GST
tag by size exclusion chromatography (Superdex 75 26/600 col-
umn, GE Healthcare) combined with a glutathione column in
phosphate buffer (50 mM KPi, 150 mM KCl, pH 6.5). The p97-
D1D2 protein was separated from cleaved GST tag by filtration
with a Centricon filter unit (30,000 molecular weight cutoff,
Amicon,Millipore, Darmstadt, Germany). The proteinmixture
containing His6-tagged p97-N was applied to an anion
exchange column (HiTrapQHP,GEHealthcare) in buffer 2 (20
mM Bis-Tris, pH 6.6) and eluted with buffer 2 additionally con-
taining 500 mM NaCl. Subsequently, the eluted protein was
loaded onto a nickel-nitrilotriacetic acid column (Macherey
and Nagel) in buffer 3 (50 mM NaH2PO4, 300 mM NaCl, 10 mM
imidazole, pH 8.0) and eluted with buffer 3 supplemented with
500 mM imidazole by a gradient. For NMR spectroscopy, pro-
teinswere dialyzed against 50mMKPi buffer, pH6.5 forUBXD1
constructs and pH 7.2 for p97 constructs, as a compromise
between high ionic strength (necessary to mimic physiological
conditions) and the technical requirements for spectroscopic
analyses (circular dichroism (CD), NMR, and fluorescence
anisotropy).
NMR Spectroscopy—NMR experiments were performed on a
700-MHz Ultrashield NMR spectrometer (Bruker, Ettlingen,
Germany) equipped with a cryoprobe (Bruker Biospin). Sam-
ples were dissolved in 600l (90%H2O, 10%D2O) of phosphate
buffer. Standard triple resonance spectra (CCCONH/
HNCC) were used for backbone assignment of UBXD1-N
(Biological Magnetic Resonance Data Bank entry 26664) and
for the complementation of the assignment of p97-N (25).
According to MALDI-TOF data of UBXD1-N, up to 16 C-ter-
minal amino acids are proteolytically degraded during purifica-
tion (data not shown) and could not be observed concomi-
tantly. A contiguous stretch between Ala31 and Glu34, which
resides within a flexible loop, also could not be detected in the
spectra. 1H-15N heteronuclear single quantum coherence
(HSQC) spectra for titration experiments were recorded with
24 scans and 2,048  256 data points for p97-N and six scans
and 2,048  256 data points for UBXD1-N. Data were pro-
cessed with Topspin 3.0 (Bruker). Titration experiments were
performed at 25 °C for p97-N and 27 °C for UBXD1-N by step-
wise addition of different concentrations of binding partner as
indicated. Intensity changes of signals were analyzed, and 1H
and 15N shifts were combined according to the following equa-
tion (26).
total  H2 0.154  N2 (Eq. 1)
Hydrogen bonds were estimated from a modified D2O
exchange experiment with UBXD1-N constructs (amino acids
1–80 and 32–133). Because freeze-drying is not possible for
intact UBXD1-N, the sample was concentrated using a Centri-
con filter unit, and buffer was repetitively exchangedwith 100%
D2O. For analysis of flexibility, hetero-steady-state NOE (het-
NOE) spectra for UBXD1-N were recorded with the corre-
sponding pulse program from the Bruker pulse program
library. The (1H)-15N NOEs were calculated from ratios of
intensities of cross-peaks in spectrameasuredwith andwithout
saturation.
CD Spectroscopy—CD experiments were performed on a
J-170 spectrometer (Jasco). Proteins were diluted up to 0.15
mg/ml in phosphate buffer (50 mM KPi, pH 6.5). CD spectra
were recorded with 30 scans at 25 °C subtracted by the blank
(buffer without protein). The content of secondary structure
was analyzed using the CDSSTR tool with the reference set
SMP56 (27–29).
Fluorescence Anisotropy—UBXD1-N and UBXD1-NR62A/L63A
were labeled with Atto594 according to the user’s manual.
p97-N (430 M), p97-D1D2 (1 mM), and p97 (290 M) were
titrated in 10 steps to labeled UBXD1 constructs as indicated.
The measurements were done in phosphate buffer (50 mM KPi,
0.05% Tween, pH 7.2) at 25 °C on a Cary Eclipse fluorescence
spectrometer (Agilent Technologies, Waldbronn, Germany).
The curves were fitted with GraphPad Prism 5.0 using a one-
site-specific binding model. All fitting curves have R2 values
between 0.93 (UBXD1-NWT and p97-N) and 0.99 (UBXD1-
NR62A/L63A and p97-D1D2).
ATPase Activity Assay—The ATPase activity of p97 was
measured with an NADH-coupled ATPase activity assay as
described elsewhere (11). 500 nM p97 protein (monomeric
form)was incubatedwith several concentrations of cofactors as
indicated in 100 mM Tris-HCl at 37 °C. The decrease in the
NADH absorption at 340 nm due to ATPase activity of p97 was
measured on a Cary 100 Bio UV/visible spectrometer (Agilent
Technologies) in real time.
Limited Proteolysis—The limited proteolysis of p97 was per-
formedwith trypsin protease (molar ratio, 1:100) in the absence
and presence of several cofactors. p47 is known to hold p97-N
in an upper conformation, and ATPS fixes the N-domain of
p97 more above the D1 ring. Additionally, we tested UBXD1-
N(1–133), which contains the p97-N binding sites in helix
(H) 1/H2 and the VIM, as well as the modified construct
UBXD1(32–133)R62A/L63A, which lacks both binding sites as a
p97-N non-binding control. The measurements were per-
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formed in phosphate buffer (50 mM KPi, pH 6.5) as described
elsewhere (11). After a 2-h incubation at 37 °C, each samplewas
mixed with SDS loading buffer and loaded for SDS-PAGE.
Results
Sequence Elements of UBXD1-N Outside of the VIM Are
Required to Functionally Cooperate with p97 at Endosomes—
When endocytic invaginations (called caveolae) are destabi-
lized, their major constituent, CAV1, is targeted to lysosomes
for degradation (21). To mediate the process, p97 and UBXD1
are recruited to CAV1-containing endosomes, which can be
stimulated by CAV1 overexpression (14, 21, 22). To analyze
the structural determinants that govern targeting of UBXD1
to p97-regulated endosomes, we transiently overexpressed
CAV1-HA with diverse variants of UBXD1-GFP (Fig. 1, A for
summary schematic and B for expression analysis). Besides
UBXD1 wild type and truncations of the N-terminal region,
variants harboring two point mutations in the VIM (R62A/
L63A) or five point mutations in the PUB domain (5xPUB),
whichwere previously shown to affect respective binding activ-
ities, were investigated (20, 23). CAV1-HAwas detected by im-
munofluorescence with HA antibodies, and colocalization of
CAV1-HA and UBXD1-GFP was visualized by epifluorescence
microscopy (Fig. 1C). UBXD1wild type largely colocalizedwith
CAV1 endosomes. Mutation of either the PUB domain
(5xPUB) or theVIM (R62A/L63A) reduced, but did not abolish,
endosome targeting. Even when both sets of mutations were
combined,UBXD1was still detectable onCAV1-positive endo-
somes. UBXD1 recruitment was only abolished when the PUB
domain mutations were combined with full truncation of the
N-terminal region covering amino acids 1–133 harboring the
VIM. These data suggest a functional significance of sequence
elements in UBXD1-N flanking the VIM for localization to
CAV1-positive structures and indicate that they may be
involved in the functional cooperation with p97.
The IsolatedUBXD1-NExhibits FourHelical Regions—Based
onUBXD1 localization studies and the lack of structural studies
of the whole N terminus (residues 1–154; Ref. 20), we focused
on the structure of this moiety of UBXD1 (UBXD1-N). Consid-
ering the importance of the VIM (residues 52–63) in p97 bind-
ing and the N-terminal residues 1–133 in endosome recruit-
ment, we cloned and expressed the full N-terminal domain
(UBXD-N(1–154)), UBXD1-N(1–133), and a minimal con-
struct (UBXD1-N(1–80)) including the VIM.We used the iso-
lated UBXD1-N as a simplified but valuable representative for
studying the structure and dynamics of the N-terminal region
in UBXD1. The 1H-15N HSQC NMR spectrum of UBXD1-
N(1–133) (Fig. 2A) showed 109NH signals, most of which were
dispersed over less than 1 ppm along the 1H dimension (7.8–
8.6 ppm). Neither extension of the N terminus of UBXD1 to
Val154 nor reduction to Arg80 had any apparent effect on signal
dispersion, indicating that all three constructs share a common
core structure. As the C-terminal residues following Arg80
FIGURE1.SequenceelementsofUBXD1-Noutsideof theVIMmediateUBXD1targeting top97-regulatedendosomes.A, schematic ofUBXD1constructs
used for cell assays. Tomonitor UBXD1 localization in U2OS cells, cells were co-transfectedwith CAV1-HA and different GFP fusions of UBXD1 as indicated. The
asterisks represent mutations. B, Western blot analysis of expression levels of GFP-UBXD1 variants. Indicated constructs were transiently co-expressed with
HA-CAV1 in U2OS cells. Cell lysates (15g) were analyzed with the indicated antibodies. -Tubulin served as a loading control. C, overexpression of CAV1-HA
induces a p97-UBXD1-mediated response at endosomes. CAV1-HA was immunostained, and localization of different UBXD1 variants to CAV1-HA-positive
endosomes was investigated. Note that endosome recruitment of UBXD1 was not affected by VIM (R62A/L63A (RL)) or PUB (5xPUB) mutation even in
combination but was abolished by full deletion of UBXD1-N together with the PUB mutation. Scale bars, 10 m. FL, full length.
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FIGURE 2. Structural investigation of UBXD1-N. A, the 1H-15N HSQC spectrum of UBXD1-N(1–133) showing 109 signals from which 96 signals could be
assigned (50mM KPi, pH 6.5). An expanded region of the central portion of the HSQC spectrum is shown in the right corner. The NH	 resonance of tryptophan
Trp71 is presented in the left corner. B, CD spectrum of UBXD1-N showing an unstructured protein with -helical character. deg, degrees. C, analysis of H
chemical shift differenceswith respect to randomcoil values (30). Sequential crowding of positive values in the bottom chemical shift index (CSI) plot indicates
helical structures. Secondary structure elements are supported by amodifiedD2O exchange experiment.D and E, chemical shift difference analysis ofmutants
of UBXD1-N deduced from 1H-15NHSQC spectra of wild type and the respectivemutant. The sites ofmutation are indicated by *. Amide resonances of shifting
residues are represented by their corresponding shift difference values. Amide resonances with chemical shift values0.1 ppm are depicted as barswith 
values of 0.1 ppm for better representation.C, C terminus.D, UBXD1-ND11A/I12A andUBXD1-NQ21A/K22A. In the case of UBXD1-ND11A/I12A (upper shiftmap) severe
changes are observed in the region of the mutation H1/H2 (Lys2–Ala17) as well as in the region of L3 (Ala61–Asn81). In contrast, the mutant protein UBXD1-
NQ21A/K22A (lower shift map) exhibiting the mutated residues in a random coil area only gives rise to chemical shift changes of resonances of residues around
the mutated sequence position. E, UBXD1-NR62A/L63A (mutation next to L3) and UBXD1-NR45A/Q46A. For UBXD1-NR62A/L63A (upper shift map), severe shifts are
induced in the region of themutation H3/L3 (Ala59–Gln67) as well as in H1/H2 (Lys2–Ala17). In contrast, themutant protein UBXD1-NR45A/Q46A (lower shift map)
exhibiting themutated residues in a random coil area only gives rise to chemical shift changes of resonances of residues surroundingmutated amino acids. F,
model of UBXD1-N implying results from chemical shift analysis, mutational studies, and hetNOE analysis. C, C terminus. G, hetNOE analysis of UBXD1-NWT.
15N-1H heteronuclear NOEs represented by the ratio of resonance intensities Isat/Iequ obtained from spectra recorded under saturated and non-saturated
conditions. 70% of the amino acids have values	0, indicating a flexible protein (values range from
0.35 to 0.48). Amino acids with positive values correlate
with the secondary structural elements H3, L3, and H4 (Thr49–Ala89).
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obviously do not influence the chemical shifts of the preceding
residues 1–80, one can exclude any strong interaction between
these stretches of amino acids. Based on these data and our
interest in the function of UBXD1-N in endosome recruitment,
we focused on the structure of UBXD1-N(1–133). Sequence-
based secondary structure algorithms predicted theN terminus
of UBXD1-N(1–133) to reveal a random coil fraction of 57%
(42% -helix and 1% -sheet) (31). These predictions were also
consistent with experimental data deduced from the secondary
structure analysis of far-UVCD spectra of the isolatedN termi-
nus ofUBXD1 (46%-helix, 18%-sheet, and 33% randomcoil;
Fig. 2B). To obtain information on the core structure of the
N-terminal domain, backbone atoms of UBXD1-N(1–133)
were assigned to their corresponding NMR frequencies by
means of HNCC for C and C atoms, HNCO/HN(CA)CO
for CO atoms, and 15N total correlation spectroscopy-HSQC
spectra for hydrogen atoms of the side chains. Due to the high
internal dynamics of UBXD1-N, only a few medium range
NOEs characterizing -helices (e.g. H(N)i,i 3; H(N)i,i 4,
etc.) were found for helices H2 and H3. However, a sufficient
amount of long range NOEs for structure calculation was gen-
erally not obtained from either two-dimensional or three-di-
mensional NOESY spectra. We refrained from calculating an
NMR-based structure of UBXD1-N, although a few long range
NOEs between the helical regions could be assigned (Table 1).
Chemical shifts from H resonances were used to predict sec-
ondary structure elements within the protein, revealing five
-helical regions (H1,Met1–Phe5; H2, Ala10–Ser25; H3, Asn50–
Gln65; H4, Asp77–Ala91; and H5, Thr102–Pro108) (Fig. 2C). The
formation of secondary structure elements in H1, in the first
part of H2, along H3 as well as partially in H4, and at the C
terminus including H5 was also confirmed by a modified D2O
exchange experiment (Fig. 2C, bars on top, H-bonds). H2 may
exist as a helix-turn-helix element with the turn at Lys15–Ala17,
and H4 is only poorly defined by the experimental data. As H1,
H2, and H4 are predominantly defined by characteristic H
shift values, all three helices are considered to be transient heli-
ces. The knownVIM (Ala52–Arg62) of UBXD1-N is a part of the
well defined H3. Despite the transient character of most of the
helices, the mutational exchange of amino acids D11A/I12A
within H2 led to significant chemical shift changes of 1H-15N
HSQC signals belonging to amide groups of residues of H1 as
well as H3/loop (L) 3 (Fig. 2D). Corresponding chemical shift
changes of signals of residues fromH1/H2 were observed upon
exchange of amino acids R62A/L63A in H3 (Fig. 2E), revealing
an interaction between these secondary structure elements.
BecauseNMR-based structure calculation and homologymod-
eling were not feasible, we used the information obtained from
experimental data (analysis of shifts and mutational studies) to
generate an ab initio model for UBXD1-N (Fig. 2F). Although
the model displays interactions of helical elements within
UBXD1-N, it implies a very dynamic structure, which was con-
firmed when retrieving information on backbone dynamics of
UBXD1-N from the hetNOE of the amide resonances (Fig. 2G).
For rigid tumbling proteins of about 14 kDa, these hetNOE
values are higher than 0.6. Low hetNOE values are correlated
with high internal flexibility. About 70% of the NH groups of
UBXD1-N revealed negative values, indicating high internal
mobility and, hence, flexibility of the backbone. Positive values
were found for H2, H3 containing the VIM, L3, and H4.
Although the positive values correlated with most of the
defined partially transient secondary structural elements and
point toward restricted backbone motility, the overall hetNOE
values were below 0.5, indicating that UBXD1-N is a flexible
region lacking a rigid three-dimensional folding topology.
UBXD1-N Binds the p97-N via Two Binding Sites—Based on
our cell biological experiments, we wondered whether the flex-
ible UBXD1-Nmoiety is capable of interacting with the p97-N.
To investigate this interaction, p97-Nwas added step by step to
15N-labeled UBXD1-N up to a molar ratio of 1:5, respectively.
The corresponding chemical shift and intensity changes of the
amide signals of residues of UBXD1-N were monitored by
1H-15N HSQC spectra. Upon titration of p97-N to UBXD1-N,
29 amide signals lost intensity, whereas another 12 signals
underwent chemical shift changes, indicating a specific inter-
action of both proteins (Fig. 3A). The affected residues accumu-
lated within two sequential stretches of UBXD1-N comprising
amino acids from Lys2 to Lys30 and Arg45 to Trp71. The first
stretch belongs toH1/H2.Upon binding of p97-N, some signals
underwent mainly small chemical shift changes (Lys2, Phe4,
Phe5, Glu7, Phe8, Asp11, and Ile12 of H1/L1 and Lys30 of H2),
whereas other signals decreased in intensity and finally disap-
peared at higher p97-N concentrations (Phe14, Ala17, Gln21,
Lys22, Lys24, and Glu25 of H2). Amino acids belonging to the
disappearing peaks occupy one side of H2, pointing toward
direct involvement in binding. The second p97-N binding
stretch of residues of UBXD1-N from Arg45 to Trp71 contains
the VIM (Ala52–Arg62), which is located in H3. Most of the
TABLE 1
Long range H-HN NOEs depicted and assigned by the software Cyana
The quality factor (0–1) indicates the reliability of the assignedNOEs. Residues that give rise to theNOEs aswell as the calculated distances of atoms are shown. Interactions
between the corresponding helices are labeled by.
Quality Peak Residues Upper distance H1-VIM H1-H2 H2-VIM
Å
0.95 205 H Lys13-H Phe5 3.45 
0.94 292 H Ile12-H Arg80 3.95 
0.86 242 H Arg80-H Asp11 3.24 
0.78 194 H Arg80-H Ile12 4.30 
0.68 279 H Lys35-H Phe4 4.83 
0.66 299 H Ile79-H Phe4 4.43 
0.48 195 H Arg62-H Ile12 4.12 
0.35 300 H Ile12-H Gln65 5.50 
0.26 305 H Leu63-H Ile12 4.77 
0.12 203 H Ala70-H Phe5 3.53 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FIGURE 3. Binding studies of UBXD1-N and p97-N. A, shift difference map deduced from 1H-15N HSQC spectra of 15N-labeled UBXD1-N in the absence and
presence of p97-N. Amide resonances of residues that shift upon p97-N binding are represented by their corresponding shift difference values. Amide
resonances of amino acidswhose intensities vanish upon binding to p97-N are represented by barswith values of 0.2 ppm. B, fluorescence anisotropy binding
studies of the UBXD1-N/p97-N interaction. Increasing amounts of p97-N were stepwise added to N-terminal Atto594-labeled UBXD1-N(1–133)WT (Œ) and
UBXD1-NR62A/L63A (f). The KD of p97-N/UBXD1-Nwas calculated to be 9M, and the KD of p97-N/UBXD1-NR62A/L63A reflecting approximately the KD of the new
binding site between H1/H2 of UBXD1-N and the linker region (amino acids 187–200) of p97-N was calculated to be 580 M. Graphs are representative. C,
chemical shift difference map deduced from 1H-15N HSQC spectra of 200 M UBXD1-NR62A/L63A in the absence and presence of 200 M p97-N. Amide
resonances of shifting residues are representedby their corresponding shift difference values. Amide resonances of aminoacidswhose intensities vanishupon
binding to p97-N are represented by barswith values of 0.2 ppm. The mutation (R62A/L63A) of the VIM in UBXD1-N leads to a loss of binding of UBXD1-N to
p97-N throughout theVIM,whereasbinding still occurs throughaminoacidsof theN terminusofUBXD1 (Gly20, Gln21, Lys22, andLys30).D, NMRsignals of amino
acids of p97-N that either shift (light blue) or decline in intensity (dark blue) upon binding of UBXD1(1–80) are mapped on the surface of the p97-N structure
(extracted N-domain including the ND1 linker in gray from Protein Data Bank code 1E32). E, surface representation of p97 N-domain with UBXD1(1–80)R62A/L63A-
interacting residues labeled as in Fig. 3D. F, section of the 1H-15NHSQCof p97-NR155H. Spectra of p97-NR155H are presented in the absence (green) and presence
(orange) of UBXD1-N(1–80). Intensities of p97-N signals from the random coil region (7.7–8.3 ppm) decrease after binding of UBXD1-N, whereas the complex
precipitates immediately. G, section of the 1H-15N HSQC of p97-NR95G. Spectra of p97-NR95G are presented in the absence (blue) and in the presence (red) of
UBXD1-N(1–80). Intensities of p97-N signals from the randomcoil region (7.7–8.3 ppm) decrease after binding of UBXD1-N, whereas the complex precipitates
after 1 day.
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signals belonging to this region disappeared in the 1H-15N
HSQC spectrum upon addition of p97-N, whereas residues
Ala57, Ala70, and Trp71 showed only marginal chemical shifts
changes. These observations suggest the direct involvement of
theVIM in binding theN-domain of p97.Moreover, the stretch
of interacting residues (27 amino acids) inUBXD1-Nwasmuch
more extended compared with the general definition of the
10-amino acid containing VIM based on bioinformatics analy-
sis of VIM-containing p97 cofactors (23). Most of the signals
with decreased intensities belong to residues of H3 containing
the VIM, whereas signals with only chemical shift changes are
concentrated in H1/H2. Signal intensity loss indicates that the
dynamics of complex formation is within the intermediate to
slow exchange regime on the NMR time scale, pointing to high
affinity binding constants of corresponding binding partners
(KD values in the lower M to nM range). Changes in chemical
shifts indicate that the exchange between bound and unbound
conformations is within the fast exchange regime on the NMR
time scale, which usually belongs to low affinity interactions
(KD values in the higher M to mM range). Therefore, we con-
cluded that theVIMand flanking residues (disappearing signals
already at molar ratios of 0.2:1) bind p97-N with a higher affin-
ity than H1/H2 (small shifts at molar ratios up to 1:5). For con-
firmation, the affinity of p97-N to UBXD1-N was calculated by
fluorescence anisotropy to be 9M,which is in accordancewith
published data (32) (Fig. 3B). The affinity for the newly identi-
fied binding region of H1/H2 was investigated using the
UBXD1-N mutant R62A/L63A, which is known to interrupt
the interaction between the VIM and p97-N (23). Fluorescence
anisotropy studies revealed thatH1/H2 bound p97-Nwith aKD
of about 580 M independently of the VIM (Fig. 3B). This is in
accordance with the observation that only signals of residues
belonging toH1/H2 decreased in their intensity and/or showed
chemical shift changes in a corresponding 1H-15N HSQC titra-
tion experiment using the UBXD1-NR62A/L63A mutant (Fig.
3C). Hence, our results confirm the presence of a high affinity
binding motif (VIM) within UBXD1-N, but moreover, they
provide evidence for the existence of an additional low affinity
binding site.
To identify the two UBXD1-N binding epitopes on p97-N,
several concentrations of UBXD1-N(1–80) (to keep themolec-
ular weight of the binding complex as low as possible) were
added gradually to 15N-labeled p97-N up to amolar ratio of 1:5,
respectively. The corresponding chemical shift changes of the
amide signals of p97-Nweremonitored by 1H-15NHSQC spec-
tra (50 mMKPi, pH 7.2). Upon binding of UBXD1-N, the inten-
sities or chemical shifts of 48 NH signals changed. The corre-
sponding residues were mapped onto the surface of the p97-N
crystal structure including the ND1 linker (extracted from Pro-
tein Data Bank code 1E32) to visualize the binding areas (Fig.
3D). Two binding interfaces could be identified. The first inter-
face comprises residues from the hydrophobic VIM-binding
groove between the two subdomains of p97-N and neighboring
residues (Val38–Gln43, Gly54, Thr56, Val88, Val87, Tyr138–
Tyr143, Ile151–Arg155, Ile175–Ile182, and Cys105–Gly111). The
second interface is composed of the linker region connecting
the N-domain to the D1 domain of p97 and of amino acids
located in close proximity on the surface of p97-N to this linker
(Arg93, Leu117, Gly156, and Cys184–Glu195). To specify which
interface of p97-N is bound either by H1/H2 or by the VIM of
UBXD1-N, the UBXD1-NR62A/L63A mutant was added to 15N-
labeled p97-N up to a molar ratio of 1:5, respectively. Upon
binding of UBXD1-NR62A/L63A, the intensities and chemical
shifts of 26 NH signals were perturbed in the corresponding
1H-15N HSQC spectra. Most of the amino acids reside within
the ND1 linker or within its neighborhood on the surface of
p97-N (Gln50, Lys60, Ser73, Arg93, Ser101, Leu117, Gly156/Gly157,
Cys184, Lys190, and Glu195 as well as Ile119, Asn130, and Asn199,
which are not bound by the wild type; Fig. 3E). Additionally,
some amino acids were affected that are not clustered and are
spread over the surface (Val39–Gln43, Asp55, Leu58, Cys105,
Leu140, Tyr143, and Thr168). Thus, we conclude that the ND1
linker of p97 is preferably the binding region for H1/H2 of
UBXD1-N, whereas the VIM binds the VIM groove between
the two subdomains of p97-N.
The binding studies described above revealed the involve-
ment of residueswithin p97-N that aremutated in patientswith
inclusion bodymyopathy associated with Paget disease of bone
and frontotemporal dementia (Arg93, Arg155, and Arg191). To
investigate the influence of these mutations on binding of
UBXD1-N to p97-N, increasing amounts of UBXD1-N(1–80)
wild type were added to a molar ratio up to 1:1 to 15N-labeled
mutant p97-NR155H (Fig. 3F) as well as 15N-labeledmutant p97-
NR95G (Fig. 3G). However, the unspecific disappearance of sig-
nals in both spectra and an instant precipitate of p97-NR155H
and 1 day later of p97-NR95G occurring within the sample sug-
gest unspecific interaction and subsequent aggregation of the
corresponding complexes, which precluded further analysis.
UBXD1-N Interacts with theD1D2Barrel of p97—In addition
to the binding sites observed for p97-N in the N terminus of
UBXD1, UBXD1-N also bound to the D1D2 barrel of p97 with
an affinity of 270 M as demonstrated by fluorescence anisot-
ropy measurements (Fig. 4A). Intriguingly, the binding of
UBXD1-Nto thep97-D1D2barrel seems tobenucleotide-inde-
pendent as the presence of ATP does not have an effect on the
KD value (270 63 M for ADP-bound versus 251 53 M for
ATP-bound). An interaction between cofactors and the D1D2
domain of p97 has not been described so far. To study this
interaction further, several concentrations of soluble p97-
D1D2 protein were added to 15N-labeled UBXD1-N up to a
molar ratio of 1:1, respectively. The corresponding chemical
shift and intensity changes of the amide signals of UBXD1-N
weremonitored by 1H-15NHSQC spectra (Fig. 4B). Upon titra-
tion of p97-D1D2 to UBXD1-N, the intensity of 38 amide sig-
nals decreased significantly, indicating a specific interaction of
both proteins. The interacting residues are clearly concentrated
in two stretches of UBXD1-N. Thereby, p97-D1D2 binds pref-
erably H1/L1 (Phe4, Phe5, Gln7, Phe8, Asp11–Phe14, and Ala17)
and H3/H4 (Glu51–Gln53, Ala55–Gln65, Gln67, Arg69–Gly72,
Thr78–Arg80, Val83–Glu86, and Gln88–Glu90) including the
known VIM (Ala52–Arg62) and its flanking residues. In com-
parison with p97-N, p97-D1D2 binds the N-terminal region of
H1/H2 (H1/H2 Met1–Ser26 and 9 affected residues within
Phe4–Ala17), whereas p97-N is primarily bound to H2 (H2
Ala10–Ser26 and 6 disappearing signals between Phe14 and
Glu25). As shown, the VIM interacts with the N-domain as well
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as with the D1D2 barrel of p97, but p97-N preferably binds the
N-terminal region of the VIM, whereas the D1D2 barrel inter-
acts with the C-terminal part of the VIM (Fig. 4C), suggesting a
different binding mechanism of UBXD1-N to the N-domain
and the D1D2 barrel of p97. This hypothesis is also in line with
fluorescence anisotropy measurements of a UBXD1 mutant
lacking a functional VIM (Fig. 4D). Although the binding of
UBXD1-NR62A/L63A to p97-N is significantly reduced due to the
mutation, it remains similar to the p97-D1D2 construct.
UBXD1-N Inhibits the ATPase Activity of p97 and Fixes the N
Domain of p97 in an Altered Conformation When Compared
with p47—Our studies indicate that the isolated N terminus of
UBXD1 binds in a similar region on p97-N as the cofactor p47.
Because p47 is known to inhibit the p97 ATPase activity (33),
we tested the ATPase activity of p97 in the presence of
UBXD1-N using an NADH-coupled ATPase assay (Fig. 5A).
UBXD1-N reduced the ATPase activity of p97 in a
concentration-dependent manner to 7.27 mol of ATP/mg of
p97/h (41%;Ki 8nM) similar to p47 (reduction to 5.59mol of
ATP/mg of p97/h; 31%; Ki  7 nM). In contrast, the addition
of Tris buffer did not have any significant effect on the p97
ATPase activity.
For the p97p47 complex, EM-based structure analysis indi-
cated that the N-domain of p97 is held in an “up” conformation
by p47 (34). Because our data indicated that the UBXD1-N
interactswith both theN-domain and theD1D2domain of p97,
wewonderedwhether UBXD1-N constrains p97-N in the same
conformation. To investigate various conformations caused by
either p47 or UBXD1-N, p97 was degraded by limited proteol-
ysis using trypsin (Fig. 5, B and for time courses C). Untreated
p97 displays a prominent band on SDS-PAGE at roughly 100
kDa (lane 1). Upon digestion, two major bands of 55 and 75
kDa (lane 2) appeared (negative control). The band patterns in
the presence of both the cofactor p47 (stoichiometry of 3:6
(p47:p97), lane 3) and the non-hydrolyzable substrate analogue
ATPS (lane 4) are comparable with the negative control (lane
2). Because the binding of p47 leads to a fixation of the p97
N-domain in an upper position (34), the corresponding confor-
mational changes made the linker between the domains of p97
accessible for enzymatic proteolysis by trypsin. Only bands cor-
responding to the rigid and protected domains of p97 are left.
The band for p47 below 55 kDa disappears due to partial deg-
radation by trypsin, whereas another band at 25 kDa appears.
LC-MS/MS analysis identified this band as parts of p47 con-
taining the Shp1-eyc-p47 domain (SEP) as well as the p97-N
binding UBX domain (data not shown). A modified UBXD1-N
construct (amino acids 32–133, R62A/L63A), which does not
bind the VIM groove of p97-N or the ND1 linker but still inter-
acts with p97-D1D2, fails to protect p97 against proteolysis
(lane 6). In this case, a similar band pattern is observed as in the
presence of p47 or ATPS (lanes 3 and 4). Only UBXD1-NWT,
which binds p97-N as well as p97-D1D2, is able to partially
protect full-length p97 from proteolysis by trypsin, resulting in
a different band pattern (100, 70, and 20 kDa; lane 5). The dif-
ferent band pattern of p97 after limited proteolysis in the pres-
ence of UBXD1-N or p47 indicates an altered conformation of
the p97 hexamer. Additionally, temperature stability experi-
ments confirmed a higher melting temperature of p97 in the
presence of UBXD1-N (88 °C) in comparison with that in its
absence (68 °C) or in the presence of its substrate analogue
ATPS (71 °C) (Fig. 5D). Due to the high Trp content of p47 (13
Trp residues) compared with p97 (3 Trp residues), it was not
possible to perform the thermal stability assay in the presence
of the cofactor p47. The altered proteolysis pattern and the high
FIGURE 4. Binding studies of UBXD1-N and p97-D1D2. A, fluorescence anisotropy binding studies of Atto594-labeled UBXD1-N with increasing amounts of
different p97 constructs. KD values of UBXD1-N binding to p97 constructs were calculated to be 9 M for p97-N (F), 270 M for p97-D1D2 (f), 251 M for
p97-D1D2ATP (; 2mMATP; normalized to p97-D1D2), and 21M for full-length p97 (Œ). Graphs are representative. B, intensity differences calculated from
amide resonancesof 1H-15NHSQCspectra of 100M15N-labeledUBXD1-N in the absence andpresenceof 200Mp97-D1D2. Bindingofp97-D1D2 toUBXD1-N
occurs in H1/L1 andH3/L3/H4. C, a comparison of the binding epitopes onUBXD1-N of p97-N (blue) and p97-D1D2 (green) reveals a similar bindingmodewith
overlap of interacting residues in the N terminus and the VIM. D, fluorescence anisotropy binding studies of N-terminal Atto594-labeled UBXD1-NR62A/L63A by
stepwise addition of p97-N (Œ) or p97-D1D2 (f). The KD for p97-N was calculated to be 580M, and the KD for p97-D1D2 was calculated to be 226M. Graphs
are representative.
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increase of the p97 melting temperature in the presence of
UBXD1-N indicate that UBXD1-N fixes p97-N in a conforma-
tion that is different from the p47-related up conformation.
This altered conformation seems to restrict the flexibility of
the N-domain and the linker regions of p97 required for the
p97 ATPase activity, explaining the observed influence of
UBXD1-N on the p97 ATPase activity.
Discussion
Among the p97 cofactors, UBXD1 is particular because it has
a complex interaction mode with p97 that is specifically
affected by disease-associated mutations in p97 (14, 23). In this
study, we report detailed data on the structure and binding
mechanismof the critical isolatedUBXD1-Nmoiety.OurNMR
and CD spectroscopic analyses of UBXD1-N have elucidated
the absence of a stable tertiary fold and the presence of stretches
of mainly transient secondary structural elements with excep-
tion of the VIM. Structural predictions using the Predictor of
Natural Disordered Regions algorithm (Fig. 6A) support the
notion that even in full-length UBXD1 no rigid three-dimen-
sional topology is present for the N-terminal region. The high
number of disorder-supporting residues (68%; namelyAla, Arg,
Gly, Gln, Ser, Glu, Lys, and Pro (35, 36)) and the presence of a
considerable number of charged amino acids (26%) argues for
an enhanced hydrodynamic radius of UBXD1-N, leading to the
short elution time in size exclusion chromatography. Taken
together, these features are consistent with the interpretation
that the N terminus of UBXD1 can be classified as an overall
intrinsically disordered region of UBXD1. Intrinsically disor-
dered proteins have attracted much attention during the last
two decades, and thus their general regulatory role in signaling
and controlling pathways is widely accepted (37–40). The
unique binding properties and the regulative potential of
intrinsically disordered regions in proteins were recently dis-
covered to appear also in cofactors of p97 (41–43). Moreover,
proteins that are involved in p97-related pathways such as
endoplasmic reticulum-associated protein degradation (44)
and the ubiquitination system for protein degradation also con-
tain unstructured amino acid stretches with regulative roles
(45).
The flexible N-terminal region of UBXD1 contains the well
defined -helical VIM, which is known to bind the groove
between the two subdomains of p97-N (23, 32). This interac-
tion was also confirmed by our NMR spectroscopic studies at
the atomic level. However, consistentwith our cell-based assays
monitoring UBXD1 localization to p97 on CAV1 endosomes,
our structural studies revealed a more complex binding mech-
anism than noted previously (23). We discovered a new inter-
action site onH1/H2 in UBXD1-N that binds the ND1 linker of
p97 independently from the VIM. TheH1/H2 binding region is
-helical and conserved among several species but unique for
the UBXD1 cofactor. UBXD1 has recently been shown to also
bind a population of ERGIC-53 at the plasma membrane with
FIGURE 5. Evidence for conformational changes of p97 during UBXD1-N binding. A, ATPase activity of p97 (F) is reduced concentration-dependently by
either p47 (f; 31%) or UBXD1-N (Œ; 41%). Graphs are representative. B, limited proteolysis of p97 (10M) using trypsin (T) in the absence of any cofactor (lane
2) or in the presence of either p47 (5 M; lane 3), ATPS (5 mM; lane 4), UBXD1-NWT (10 M; lane 5), or UBXD1-N(32–133)R62A/L63A (RL; 10 M; lane 6). C, limited
proteolysis at time points as indicated for p97, p47 and p97, ATPS and p97, UBXD1-NWT and p97, and UBXD1-NR62A/L63A and p97. Differences in the band
pattern after digestion of p97 with trypsin are indicated by arrowheads.D, stability of p97 (F) or p97 in the presence of the non-hydrolyzable substrate ATPS
(f) or UBXD1-N(1–133) (Œ) wasmonitored by following the intrinsical tryptophan fluorescence during stepwise heating of the samples. Melting of p97 in the
absence of any compound occurs at 68 °C. Binding of either ATPS or UBXD1-N led to higher melting temperatures of 71 and88 °C, respectively, pointing
toward higher stability of p97. Data are presented as the ratio between the highest Trp fluorescence at 328 nm and the fluorescence at the specific tempera-
ture. Lane M, molecular weight markers; , minutes.
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the very N-terminal amino acids (46). Intriguingly, this region
overlaps with the H1/H2 binding site for p97, and therefore it
would be interesting to clarify whether these differential inter-
actions of UBXD1 represent alternative functions or whether
they are functionally linked. Additionally, both binding regions
of UBXD1-N are also involved in the interactionwith theD1D2
barrel of p97. The binding of p97-N and -D1D2 seems to occur
simultaneously because there is only a partial overlap of binding
epitopes on UBXD1-N. Although we were not able to identify
the binding interface on p97-D1D2 exactly, we assume that
binding occurs to the D1 domain as UBXD1-N binds residues
of the interface between the N-domain and D1 domain as well
as the linker between the N-domain and the D1 domain of p97
(Fig. 6B).
The intrinsically disordered region characteristic of
UBXD1-N and the absence of a defined tertiary structure may
affect the ability of the protein to properly fit into the poly-
epitopic interface region on the p97 protein. In fact, we suggest
that the intrinsic flexibility of UBXD1-N may be a structural
requirement for targeting the VIM groove of p97-N while
simultaneously grabbing the flexible ND1 linker and the D1D2
barrel at a very far distance. Of note, in a number of cofactors,
short p97-bindingmotifs lie in regions without defined domain
structure for example in UBE4B, small VCP-interacting pro-
tein, VCP-interacting membrane protein, Hrd1, and autocrine
motility factor receptor (43, 47–50). Moreover, the VIM pro-
tein small VCP-interacting protein was also shown to bind the
ND1 linker (32, 41). Based on our new data on UBXD1-N, we
therefore propose that polyvalent binding of intrinsically disor-
dered regions containing short p97-binding motifs is a more
general feature of a number of p97 cofactors and thereby
defines a subclass of cofactors.
Two additional observations in this study are consistent with
the notion that UBXD1-N intercalates in a complex manner
and possibly affects the flexibility of the N-domain. First, we
show that UBXD1-N binding to p97 changes the protease sen-
sitivity of p97 in comparisonwith p47. These changes can either
occur from protection of proteolysis sites or from domain
reorientation. We assume that the changed protease pattern
results from domain reorientation because the proteolysis pat-
tern of free p97 does not change upon binding of the cofactor
p47, althoughUBXD1-Nandp47 share a similar binding site on
p97-N. p47, however, is known to lock p97-N in an up confor-
mation. Considering the additional binding site of UBXD1-N
on theD1D2 barrel and the fact that only two extreme positions
of the p97 N-domain are realized within the hexamer, it is rea-
sonable to assume that UBXD1-N locks p97-N in a “down”
conformation toward theD1D2barrel. Another indication for a
compaction of p97UBXD1-N is theUBXD1-N-mediatedmelt-
ing temperature increase of p97 (about 20 °C). Because a long
intrinsically disordered protein chain should lead to a strong
positive
TS contribution to theGibbs free enthalpy, such an
unfavorable contribution can be overcompensated by addi-
tional newbinding sites formed in the presence ofUBXD1-Nby
intradomain/domain interaction as postulated to occur upon
formation of the down conformation. Second and connected to
the first, UBXD1-N binding to p97 inhibits its ATPase activity.
Previous reports have established that p97-Nmotion relative to
the D1 plane is coupled to ATPase activity and that locking the
N-domain in a down position inhibits ATPase activity (11).
Moreover, the contact between the N-domain and the D1
domain is important for the allosteric communication between
substrate adaptor binding and ATPase domains (9, 11, 51). We
therefore speculate that binding of UBXD1-N into the p97-
ND1 interface may prevent p97-N motion and thus inhibit
ATPase activity (Fig. 6B). An analogous explanation has been
suggested for the inhibitory effect of the p47 cofactor on the
ATPase activity; only in this case, p47 locks the N-domain in an
up position (33, 34). This, in turn, is consistent with the differ-
ential effect on protease sensitivity compared with UBXD1-N
in our experiments. Following this idea of the intrinsically dis-
ordered region being a prerequisite for tethering the p97
domains and fixing them in a compact formation, the intrinsi-
cally disordered region characteristics are consecutively
responsible for the decrease of p97 ATPase activity. Previously,
N-terminally tagged full-length UBXD1 was reported to have
no effect on p97 ATPase activity (52). We assume that the iso-
lated UBXD1-Nmoiety is decoupled from regulatory elements
of the protein and that pausing p97-N motions can only be a
transient step in the context of the p97-mediated substrate pro-
tein remodeling reaction. Conversely, the specific inhibition of
the ATPase activity of p97 by the N terminus of UBXD1 sup-
ports the notion that the intrinsic features of UBXD1-N also
apply in the context of the full-length protein. Although the
substoichiometric inhibition of p97 by UBXD1-N is quite
unusual, such phenomena have already been described for oli-
gomerizing protomers (53–57). Therefore, we hypothesize a
kind of sustainability of the UBXD1-N interaction with the p97
hexamer. In any case, the specific mode of interaction between
UBXD1-N and p97 points to a distinct modulation of the p97-
mediated segregation mechanism particularly required in
UBXD1-regulated processes as opposed to p47- or Ufd1-Npl4-
regulated reactions (1, 58).
The binding mechanism of UBXD1-N to p97 may also be
relevant for p97-associated diseases. Disease-causing muta-
tions all lie at the critical interface between the p97 N-domain
and D1 domain and are believed to affect their allosteric com-
munication (4). Crucially, we show here that UBXD1-N bind-
ing occurs at this interface and even involves residues mutated
in the disease. Moreover, we showed earlier that binding of
UBXD1, but not p47 or Ufd1-Npl4, which have different bind-
ing epitopes on p97, to disease-associated p97 mutants is spe-
cifically reduced (14). Consistently, compromised sorting of
caveolin-1 is a dominant feature in cells expressing disease-
FIGURE6.Modelof thebinding interfaceofUBXD1-Nandp97.A, Predictor ofNaturalDisorderedRegions analysis of theN terminusofUBXD1 in the context
of the full-length UBXD1 protein. B, ATP hydrolysis in the p97-D2 domain is coupled to motions of the N-domain via a chain of conformational changes
involving theD1 domain and theND1 linker of p97. Insertion of UBXD1-N into the ND1 interface ismediated by interactionwith the N-domain, the ND1 linker,
and parts of the D1D2 barrel of p97. As a result, the flexibility of the N-domain is restricted, and the ATPase activity of p97 is decreased. This mechanismmay
be transient in the context of a complex p97-mediated segregation reaction. Thebinding sites involve residuesmutated in p97-associateddisease, suggesting
that effects on UBXD1-N binding may form the basis for the disease pathogenesis. aa, amino acid.
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associatedmutants of p97 (14).We therefore speculate that the
intimate intercalation of UBXD1-N into the p97-ND1 interface
constitutes the specific structural basis for the pathogenic
mechanism observed in the case of p97 disease-associated
mutations.
From our structural analysis of the isolated N terminus of
UBXD1 and further biophysical binding studies with single
domains of p97, we conclude that the UBXD1-N engages in
polyvalent binding to several regions within the ND1 domain
interface of p97. Our findings indicate that UBXD1-N interca-
lates into the p97-ND1 interface, therebymodulating the inter-
domain communication of p97 domains and hence inhibiting
its ATPase activity in a similar way to p47. We propose that
such a polyvalent binding mode is facilitated by the fact that
UBXD1-N is highly flexible and/or intrinsically disordered and
that this is a more general principle that defines a new subset of
p97 cofactors containing short p97-binding motifs in regula-
tory disordered regions. Moreover, the facts that UBXD1-N
interaction sites include those residues frequently mutated in
patients with inclusion body myopathy associated with Paget
disease of bone and frontotemporal dementia and that UBXD1
binding is affected in the disease model suggest that this partic-
ular binding mode also may have relevance for disease
pathogenesis.
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